By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Jerini AG 

Invalidenstrasse 130

Berlin    10115  Germany
Phone: 49-30-97893-0 Fax: 49-30-97893-105



Start Up

Company News
Jerini AG Reports First Quarter 2009 Financial Results 5/15/2009 2:39:28 PM
Jerini AG Receives Request for Transfer of Minority Shareholders' Shares in Jerini AG to Shire Deutschland Investments GmbH 12/16/2008 12:01:19 PM
Jerini AG Reports Financial Results for First Nine Months of 2008 11/14/2008 8:52:24 AM
Jerini AG To Divest Jerini Ophthalmic, JPT Peptide Technologies GmbH, And Jerini's Pre-Clinical Projects 10/10/2008 7:36:12 AM
Jerini AG's Management and Supervisory Boards Recommend That Jerini Shareholders Accept Shire Limited's Takeover Offer 8/25/2008 9:29:47 AM
Jerini AG Reports Financial Results for First Half 2008 8/14/2008 9:30:46 AM
Shire Limited Announces Holding of 81% in Jerini AG and Publication of Offer Document 8/13/2008 10:48:52 AM
Jerini AG Receives European Commission Approval for FIRAZYR(R) (Icatibant) in the Treatment of HAE 7/15/2008 7:27:27 AM
Shire Limited to Buy German Biotech Jerini AG for $518 Million 7/3/2008 6:40:15 AM
Jerini AG to Submit Complete Response to the FDA for Icatibant in the Treatment of HAE 6/23/2008 1:54:58 PM